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Caspase-1-mediated detection of pathogens is a potent arm of the innate immune system. LaRock and
Cookson (2012) show that the Yersinia type III secretion effector, YopM, directly inhibits caspase-1.The innate immune system detects path-
ogens through cytosolic inflammasomes,
including the Nod-like receptors (NLRs)
NLRP3, NLRC4, and NLRP1b. These
signaling platforms recruit the adaptor
protein ASC into a single focus. The ASC
focus subsequently recruits the enzyme
caspase-1, which autoprocesses and
promotes the secretion of the proinflam-
matory cytokines IL-1b and IL-18 that
initiate immune responses. Underscoring
the importance of caspase-1 in the innate
immune response, mice deficient in cas-
pase-1 fail to control many pathogenic
infections. Many viruses have developed
direct mechanisms to suppress either
caspase-1 or IL-1b, delaying the onset
of the innate immune response. For
example, poxviruses encode direct inhib-
itors of caspase-1, such as CrmA, as well
as analogs of the mammalian pyrin-only
proteins that likely prevent ASC oligomer-
ization (Taxman et al., 2010). Further,
Kaposi’s sarcoma-associated herpes-
virus (KSHV) encodes a NLR analog
that inhibits inflammasome oligomeriza-
tion (Gregory et al., 2011). Macrophages
detect Salmonella Typhimurium though
the NLRC4 inflammasome when the S.
Typhimurium type III secretion system
(T3SS) inadvertently translocates flagellin
or T3SS rod proteins into the host cell
cytosol. S. Typhimurium indirectly evades
this detection by repressing flagellin ex-
pression and using an alternate NLRC4-
evading T3SS rod proteins (Miao and
Rajan, 2011). However, bacterial viru-
lence proteins that directly inhibit in-
flammasome pathways have not been
identified. Yersinia drastically modulates
the host environment and suppresses
immune signaling by delivering effectors
(Yops) into the host cytosol via its T3SS.
In this issue of Cell Host & Microbe,
LaRock and Cookson elegantly demon-
strate that the Yersinia T3SS effectorYopM directly inhibits caspase-1 and
that this inhibition is essential for Yersinia
pseudotuberculosis virulence in vivo
(LaRock and Cookson, 2012).
In their report, wild-type Y. pseu-
dotuberculosis failed to activate cas-
pase-1, whereas caspase-1 was robustly
activated in response to a strain defi-
cient in all known T3SS effector Yop
genes (YersiniaD lacking YopJOEHKM).
Remarkably, LaRock and Cookson found
that evasion of caspase-1 was entirely
attributed to yopM. This was proven using
a strain deficient only in yopM, com-
plementing DyopJOEHKM with plasmid
borne yopM, and retrovirally transducing
macrophages with yopM in the absence
of bacterial infection. It has long been
known that the DyopM mutant is highly
attenuated, although its function in vivo
has remained elusive. LaRock and Cook-
son nail down the importance of YopM-
mediated caspase-1 inhibition by demon-
strating thatDyopM becomes fully virulent
in caspase-1-deficient mice (LaRock and
Cookson, 2012).
Significantly, LaRock and Cookson
provide amechanism by which a bacterial
virulence factor inhibits caspase-1 activity
(Figure 1). Several viruses inhibit caspase-
1 by expressing proteins that mimic the
caspase-1 binding and cleavage motif
and thus act as pseudosubstrates that
block the caspase-1 catalytic site. By
aligning YopM to known caspase-1 sub-
strates and inhibitors, the authors iden-
tified a caspase-1-binding motif. The
critical aspartic acid residue within this
motif was required for direct YopM bind-
ing to activated caspase-1. Interestingly,
the YopM C terminus directs nuclear
localization, and this domain is distinct
from the caspase-1-binding site (Benab-
dillah et al., 2004). LaRock and Cookson’s
data suggest an intriguing model in which
YopM carts caspase-1 into the nucleus,Cell Host & Microbe 12, Dmaking it unavailable for recruitment to
the cytosolic ASC focus. Indeed, the
NLRP3-ASC focus still forms, yet YopM
prevents caspase-1 accumulation in this
focus.
Several groups previously investi-
gated inflammasome detection of
Y. enterocolitica, Y. pseudotuberculosis,
and Y. pestis, focusing on YopE, YopJ,
and YopK. These reports must now be
reinterpreted in light of YopM suppres-
sion. It is worth noting that the use of
different cell lines (primary versus immor-
talized), macrophage priming conditions,
and Yersinia strains may explain the
differences in the relative contribution of
different Yops in suppressing caspase-1
activation. For example, Schotte et al.
(2004) reported that Y. enterocolitica
DyopHOPEMT triggered IL-1b secretion
and suggested that YopE, but not YopM,
was the critical effector blocking this
response. However, they examined only
a single macrophage cell line in the
absence of priming, with complementary
studies in caspase-1-overexpressing cell
lines. Does caspase-1 activation in these
cell lines accurately reflect detection
pathways occurring in primary macro-
phages and in vivo?
Later, usingaplasmid-curedY.pseudo-
tuberculosis strain containing the Y. pestis
virulence plasmid deleted for all known
Yop effectors (yopM, yopT, yopK, ylpA,
yopE, yadA, ypkA, yopJ, yopH) and
several other open reading frames, YopK
was implicated in decreasing caspase-1
activation and IL-1b secretion (Brodsky
et al., 2010). YopK interacts with the
YopBD translocon, and in the absence
of all known Yops, adding back YopK
results in decreased caspase-1 activa-
tion. Pore-forming toxins are detected
through NLRP3. Thus, in the absence
of YopK, does the YopBD translocon
pore become dysregulated, permittingecember 13, 2012 ª2012 Elsevier Inc. 737
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Figure 1. YopM Inhibits Caspase-1
Yersinia T3SS activity is detected by cytosolic inflammasomes by unknown mechanisms. Oligomerized
NLR inflammasomes recruit the adaptor protein ASC through homotypic interactions between CARD
(pink) or pyrin (purple) domains. ASC is composed of a CARD and a pyrin domain and subsequently
collects the entire complement of cellular ASC into a single focus. The ASC-CARD domains then recruit
pro-caspase-1 via its CARD domain, resulting in its autoproteolytic processing and activation. YopM
contains a pseudosubstrate binding site that binds and retains activated caspase-1. Because YopM
contains a nuclear localization signal, sequestration of activated caspase-1 in the nucleus may be a key
mechanism by which YopM separates caspase-1 from its intended targets.
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quent NLRP3 activation? Interestingly,
yopK mutants have an increased rate of
translocation of other effectors, including
YopM (Dewoody et al., 2011). Are
increased amounts of T3SS rod protein
and flagellin aberrantly injected into the
cell to be detected though NLRC4?
Perhaps in the absence of YopK, rapid
detection kinetics though multiple path-
ways overcome the ability of YopM to
block caspase-1.
In stark contrast to YopM/YopK sup-
pressing inflammasome activation, YopJ
(a MAPK and IKKb inhibitor also known
as YopP in Y. enterocolitica) induces
NLRP3-dependent caspase-1 activation
and IL-1b secretion in the absence of
priming (Viboud and Bliska, 2005). Inter-
estingly, YopJ/YopP isoforms that are
more catalytically active are more readily
detected, with IL-1b secretion at 8–24 hr
postinfection (Zheng et al., 2012). This is
quite delayed compared to typical inflam-738 Cell Host & Microbe 12, December 13, 20masome agonists such as S. Typhimu-
rium, ATP, or Alum. Are these delayed
kinetics due in part to YopM? To fully
understand the ability of inflammasomes
to detect the catalytic activity of
YopJ, experiments comparing wild-type,
DyopM, DyopJ, and DyopMJ in primed
as well as unprimed macrophages would
be informative.
Although LaRock and Cookson show
that caspase-1 inhibition is the primary
function of YopM, it may have other
functions. YopM is polymorphic, and
the number of leucine-rich repeats,
which mediate protein-protein interac-
tions, varies between strains. One could
imagine that by adding more leucine-rich
repeats, a greater surface area for binding
host proteins could be created. YopM
binds two host serine/threonine kinases
(RSK1 and PKN2) (Viboud and Bliska,
2005). Does YopM bind caspase-1 and
RSK1/PKN2 at the same time and
sequester all three in the nucleus? Thus,12 ª2012 Elsevier Inc.it is possible that YopM plays different
functions in different Yersinia species
and/or targeted cell types.
In summary, LaRock and Cookson
provide convincing data that the T3SS
effector YopM promotes Yersinia viru-
lence by inhibiting caspase-1 activation,
presumably permitting early replication
in the absence of an inflammatory
response. This story exemplifies the com-
plex interplay between innate immune
responses and bacterial evasion strate-
gies. Whereas delivery of effectors by
the T3SS into the host cytosol is a
highly efficient mechanism by which
pathogens modify the host environment
to their advantage, it also provides a
smorgasbord of bacterial ligands and
cellular perturbations that can be de-
tected by cytosolic sensors. In Yersinia,
YopM counters this inherent weakness
in the system.
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